US 11331346
Targeted replacement of endogenous T cell receptors
granted A61KA61K40/11A61K40/32
Quick answer
US patent 11331346 (Targeted replacement of endogenous T cell receptors) held by The Regents of the University of California expires Mon May 12 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue May 17 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 12 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K40/11, A61K40/32, A61K40/4269